SERPINA1 and alpha 1-antitrypsin deficiency: In summary, increasing consideration should be given to the incorporation of SERPINA1 sequencing into the AATD screening process to capture those individuals who may not present with a low A1A level or a detectable pathogenic allele on PI typing.